TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiation therapy

被引:0
|
作者
Gao, Chan [1 ]
机构
[1] City Hope Natl Canc Inst, Duarte, CA USA
关键词
D O I
10.1158/1535-7163.TARG-13-C285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
C285
引用
收藏
页数:1
相关论文
共 50 条
  • [1] TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
    Gao, Chan
    Kozlowska, Anna
    Nechaev, Sergey
    Li, Haiqing
    Zhang, Qifang
    Hossain, Dewan M. S.
    Kowolik, Claudia M.
    Chu, Peiguo
    Swiderski, Piotr
    Diamond, Don J.
    Pal, Sumanta K.
    Raubitschek, Andrew
    Kortylewski, Marcin
    CANCER RESEARCH, 2013, 73 (24) : 7211 - 7221
  • [2] An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
    Zhang, Huagang
    Liu, Laibin
    Yu, Dong
    Kandimalla, Ekambar R.
    Sun, Hui Bin
    Agrawal, Sudhir
    Guha, Chandan
    PLOS ONE, 2012, 7 (05):
  • [3] Development of TLR9 agonists for cancer therapy
    Krieg, Arthur M.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05): : 1184 - 1194
  • [4] Modulation of the tumor microenvironment by the TLR9 agonist EnanDIM and combination with checkpoint inhibition for cancer immunotherapy
    Kapp, K.
    Volz, B.
    Oswald, D.
    Wittig, B.
    Schmidt, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell In Vivo
    Ren, Tao
    Xu, Lin
    Jiao, Shuxian
    Wang, Yanying
    Cai, Yingyun
    Liang, Yongjie
    Zhou, Ya
    Zhou, Hong
    Wen, Zhenke
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (04) : 623 - 630
  • [6] Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand
    Preville, Xavier
    Rittner, Karola
    Fend, Laetitia
    ONCOIMMUNOLOGY, 2015, 4 (05):
  • [7] Modulation of checkpoint expression in tumor microenvironment by intratumoral administration of a novel TLR9 agonist: Rationale for combination therapy
    Jiang, Wayne
    Wang, Daqing
    Zhu, Fugang
    Bhagat, Lakshmi
    DiMuzio, Jillian
    Agrawal, Sudhir
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [8] Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes
    Meseure, Didier
    Vacher, Sophie
    Alsibai, Kinan Drak
    Trassard, Martine
    Nicolas, Andre
    Leclere, Renaud
    Lerebours, Florence
    Guinebretiere, Jean Marc
    Marangoni, Elisabetta
    Lidereau, Rosette
    Bieche, Ivan
    CANCER MICROENVIRONMENT, 2016, 9 (2-3) : 107 - 118
  • [9] Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy
    Wang, Daqing
    Jiang, Wayne
    Zhu, Fugang
    Mao, Xianzhi
    Agrawal, Sudhir
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (03) : 1193 - 1203
  • [10] A novel TLR9 agonist as experimental therapy for prostate cancer
    Rayburn, E. R.
    Wang, H.
    Zhang, R.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 161 (03) : 211 - 212